Dr. Samuel Polen Freedman, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-657-6742 |
Dr. David James Lindquist, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-657-8440 |
Rebecca Duby, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-656-1631 |
Megan Panapa, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-656-1631 |
Yo Herman Atteberry, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-657-6742 |
Dr. Lowan Stewart, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-657-6742 |
Jonathan Peter Yarris, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-656-1631 |
Dr. Donald Joseph Schiller, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-656-1631 |
Daniel Harry Hubbard, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Department Of Emergency Medicine, Oregon City, OR 97045 Phone: 503-853-9868 |
Michelle Roseann Shaw, M.D. Emergency Medicine - Emergency Medical Services Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-449-3964 |
Michael H Herndon, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Division St, Oregon City, OR 97045 Phone: 503-650-6255 |
News Archive
The American Association for the Advancement of Science (AAAS) has honored Mary Helen Immordino-Yang with the AAAS Early Career Award for Public Engagement with Science for her "sustained commitment and novel approach to integrating public engagement with science into her extensive research and scholarly activities and for using public interactions to inform her research."
In a study that included nearly 30,000 women from Nordic countries who had filled a selective serotonin reuptake inhibitor (SSRI) prescription during pregnancy, researchers found no significant association between use of these medications during pregnancy and risk of stillbirth, neonatal death, or postneonatal death, after accounting for factors including maternal psychiatric disease, according to a study in the January 2 issue of JAMA.
Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that it has raised $33.9 million in a Series B funding round, led by new investor, New Enterprise Associates ("NEA"), one of the world's leading venture capital firms. Existing investor, Sofinnova Partners, also participated in the financing.
The Boston Globe: Massachusetts officials are holding public comment sessions on a proposed sale of chain of hospitals in the state, and "scores of local officials, state representatives, community leaders, and employees and retirees of Caritas hospitals in Eastern Massachusetts have paraded to the podium to praise Caritas management and the private equity firm, Cerberus Capital Management, that has pledged to preserve the chain of six hospitals, at least for three years."
A man-made chemical compound called ARC causes tumor cells to die but leaves normal cells unharmed, researchers at the University of Illinois at Chicago report in a study highlighted in the March 15 issue of Cancer Research.
› Verified 9 days ago